ERO1A and neoplasm: Recent studies demonstrated that miR-218-5p served as a tumor suppressor to inhibit tumor growth and development by targeting endoplasmic reticulum oxidoreductase one alpha (ERO1A), COMMD8, CDK6, and EGFR in lung, liver, and gastric cancer [33,70,71,72].